Mathematical models and recent data from ecological, observational, and experimental studies show that antiretroviral therapy (ART) is effective for both treatment and prevention of HIV, validating the treatment as prevention (TasP) approach. Data from a variety of settings, including resource-rich and -limited sites, show that patient attrition occurs at each stage of the human immunodeficiency virus (HIV) treatment cascade, starting with the percent unaware of their HIV infection in a population and linkage to care after diagnosis, assessment of ART readiness, receipt of ART, and finally long-term virologic suppression. Therefore, in order to implement TasP, we must first define practical and effective linkage to care, acceptability of tr...
BACKGROUND: The anticipated scale-up of antiretroviral therapy (ART) in high-prevalence, resource-co...
Despite the success of antiretroviral therapy (ART) in decreasing mortality for HIV-1-infected patie...
<p>Types of ART programme may vary by availability of laboratory tests (CD4 count and viral load tes...
Mathematical models and recent data from ecological, observational, and experimental studies show th...
Potent antiretroviral therapy (ART) reduces mortality and morbidity in people living with HIV by red...
Potent antiretroviral therapy (ART) reduces mortality and morbidity in people living with HIV by red...
Antiretroviral therapy (ART) improves the health and increases the longevity of people infected with...
Abstract The experiences of the past 10 years have shown that it is feasible to treat HIV infected p...
Antiretroviral therapy (ART) for HIV infection was oneof the most spectacular scientific advances in...
The anticipated scale-up of antiretroviral therapy (ART) in high-prevalence, resource-constrained se...
Recent scientific advances have shown that antiretroviral therapy (ART) not only preserves the healt...
From the perspective of the ongoing COVID-19 pandemic, where evidence on effective prevention and tr...
(See the editorial commentary by Lange, on pages 801–802.) For individuals with human immunodeficien...
Recent advances in antiretroviral therapy (ART) have drastically improved the quality of life for pe...
Background: Roughly 3 million people worldwide were receiving antiretroviral therapy (ART) at the en...
BACKGROUND: The anticipated scale-up of antiretroviral therapy (ART) in high-prevalence, resource-co...
Despite the success of antiretroviral therapy (ART) in decreasing mortality for HIV-1-infected patie...
<p>Types of ART programme may vary by availability of laboratory tests (CD4 count and viral load tes...
Mathematical models and recent data from ecological, observational, and experimental studies show th...
Potent antiretroviral therapy (ART) reduces mortality and morbidity in people living with HIV by red...
Potent antiretroviral therapy (ART) reduces mortality and morbidity in people living with HIV by red...
Antiretroviral therapy (ART) improves the health and increases the longevity of people infected with...
Abstract The experiences of the past 10 years have shown that it is feasible to treat HIV infected p...
Antiretroviral therapy (ART) for HIV infection was oneof the most spectacular scientific advances in...
The anticipated scale-up of antiretroviral therapy (ART) in high-prevalence, resource-constrained se...
Recent scientific advances have shown that antiretroviral therapy (ART) not only preserves the healt...
From the perspective of the ongoing COVID-19 pandemic, where evidence on effective prevention and tr...
(See the editorial commentary by Lange, on pages 801–802.) For individuals with human immunodeficien...
Recent advances in antiretroviral therapy (ART) have drastically improved the quality of life for pe...
Background: Roughly 3 million people worldwide were receiving antiretroviral therapy (ART) at the en...
BACKGROUND: The anticipated scale-up of antiretroviral therapy (ART) in high-prevalence, resource-co...
Despite the success of antiretroviral therapy (ART) in decreasing mortality for HIV-1-infected patie...
<p>Types of ART programme may vary by availability of laboratory tests (CD4 count and viral load tes...